fashion -WSS

fashion

author：fashion 2025-10-01 12:11:44 - browse：522

Closeup of a human brain affected by Alzheimer's disease, on display at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y. — A brain affected by Alzheimer's disease, at the Museum of Neuroanatomy at the University at Buffalo. David Duprey/AP

Investigators on Wednesday released the first detailed case report about a patient who died after receiving lecanemab, providing a new glimpse into safety concerns surrounding the closely watched experimental Alzheimer’s drug.

An unpublished version of the report was previously written about by Science in November, one of three deaths from the lecanemab trials revealed by Science and STAT. But the published version, in the New England Journal of Medicine, will allow doctors to evaluate the case as they consider whether and how to use a treatment that could be approved by the FDA as soon as this week.

This “will have greater impact on clinicians because it is peer-reviewed and published in the New England Journal,” said Lon Schneider, an Alzheimer’s expert at University of Southern California, who was not affiliated with the work.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Shingles, which affected Dianne Feinstein, is on the rise

WSS

Bird flu makes raw milk dangerous to consume, mouse study finds

After a drawn out lobbying fight, ARPA

Cigna to pay $172 million to settle Medicare Advantage fraud probe

New research sheds light on how often breast cancer is overdiagnosed

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Achieving telehealth equity for people with hearing loss

focus

fashion

focus

How one medical school became remarkably diverse

Inequities make cancer less preventable for women: report

Supreme Court strikes down use of affirmative action

Sudafed saga points to U.S. issues with evaluating older drugs

Activists slam private health insurers over coverage restrictions

Congress: Prevent baby formula shortages by passing a new bill

The high cost of giving birth even with insurance

Should insurance cover cosmetic surgery?

Moonlake's readout produced a cash windfall. Risks remain

How one patient went off dialysis — and others can too

explore

Should insurance cover cosmetic surgery?

Guardant Health colon cancer test endorsed by FDA advisory panel

Ionis has late

Why we need mandatory labeling of GMO products

Asahi Kasei to buy Calliditas, picking up kidney disease drug

STAT Virtual Event: How to Increase Diversity in Clinical Trials

entertainment

focus

leisure time

entertainment